187
Views
31
CrossRef citations to date
0
Altmetric
Review

Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem

, , , , , , , , & show all
Pages 227-237 | Published online: 10 Aug 2017

Abstract

The prevalence of cholangiocarcinoma (CCA) in Southeast Asia is much higher than other areas of the world. Eating raw, fermented, or undercooked cyprinid fish, infected with the liver fluke, Opisthorchis viverrini sensu lato (sl), results in chronic biliary inflammation, periductal fibrosis, and increased cancer risk. There may be associated glomerulonephritis. The process of infection is difficult to disrupt because eating practices have proven extremely difficult to change, and the life cycle of the fluke cannot be broken due to high prevalence in canine and feline reservoir hosts. Fecal analysis and enzyme-linked immunosorbent assay tests can be used to diagnose opisthorchiasis. Diagnosis of CCA is complex, partly due to the lack of definitive imaging characteristics but also due to the difficulty of obtaining samples for cytology or histology. This cancer has proven to be resistant to common chemotherapy treatments and so the two avenues of treatment available are surgical resection and liver transplantation, both requiring early detection of the tumor for the best chances of success. Late presentation of symptoms reduces the chances of successful surgical intervention. While liver fluke infections can be treated with praziquantel, individuals will often become reinfected, and multiple reinfections can be more harmful than a singular, long-term infection. A key research on the detection and characterization of novel biomarkers in all parts of the carcinogenic pathway for early diagnosis is needed.

Biology of Opisthorchis viverrini

Opisthorchis viverrini sl is a human liver fluke that currently infects 10 million people in Northeast Thailand and in Lao Peoples’ Democratic Republic.Citation1,Citation2 It is a species complex, comprising many genetically distinct cryptic species (some of which are morphologically identical) that infect different genetic populations of snails, associated with specific river wetlands. Thus, it is referred to as Opisthorchis viverrini sensu lato (sl), or O. viverrini sl.Citation3,Citation4 The first intermediate hosts in the life cycle () are Bithynia snails, a species complex comprising at least 11 cryptic species corresponding to O. viverrini sl. Hence, there is a high degree of genetic variation in both species complexes associated with geographical location (such as between the Chi River wetlands and the Nam Ngum River wetlands)Citation5 (; ).

Figure 1 Life cycle of Opisthorchis viverrini sensu lato.

Note: Courtesy of Nadda Kiatsopit.
Figure 1 Life cycle of Opisthorchis viverrini sensu lato.

Figure 2 A map of river wetlands showing the geographical distribution of cryptic species of Bithynia snails.

Notes: lists the details of locations marked by abbreviations. Reproduced with permission from Saijuntha W, Sithithaworn P, Wongkham S, et al. Evidence of a species complex within the food-borne trematode Opisthorchis viverrini and possible co-evolution with their first intermediate hosts. Int J Parasitol. 2007;37(6):695–703.Citation3
Figure 2 A map of river wetlands showing the geographical distribution of cryptic species of Bithynia snails.

Table 1 Details of locations from which cryptic species of Bithynia have been found

These snails, Bithynia siamensis goniomphalos, Bithynia siamensis, and Bithynia funiculata (), are the first intermediate hosts of O. viverrini sl, up to 8.37% of which can be infected, although in most regions it is <1%.Citation5Citation8 Once the mature cercariae (larval trematode worms) have developed, they exit the snail host into the water and actively seek the secondary intermediate host, fish of the Cyprinidae family.Citation9 Over 3 weeks, the cercariae develop to become infectious metacercariae (encysted larva).Citation10Citation12 The fish accumulate infectious metacercariae, particularly in the head and fin regions, and have a much higher prevalence of infection, ranging from 42.9% (in Henicorhynchus lineatus) to 100% (in Amblyrhynchichthys truncates).Citation13 Humans may become infected when they eat infected cyprinid fish without heating the flesh sufficiently in raw, partially cooked, or fermented dishes such as Koi Pla.Citation14,Citation15 Dishes such as this are socially and culturally significant, making the encouragement of changes to eating patterns challenging.Citation16 Reinfection is therefore commonplace despite the ease of treating infection using praziquantel.Citation17

Ingested metacercariae hatch out in the duodenum before moving through the common bile duct to the distal bile duct, where they mature over a period of 2 months.Citation10,Citation11 Canines and felines function as reservoir hosts. Cats seem to have a higher prevalence of infection than dogs (36.4% as opposed to 3.8%), and this may be to do with the method of transmission.Citation18 These animals are often fed leftovers (fitting in with the traditional lifestyle of families eating raw fish), and cats appear to have a greater tendency to eat the fish heads and fins left for them.Citation18 Adult liver flukes produce eggs in the gall bladder, bile duct, and pancreatic duct, which enter the digestive system in the bile and are expelled along with feces. Fecal contamination of water containing Bithynia snails is a big problem and causes completion of the life cycle (). Although poor sanitation may be a major cause of human feces entering freshwater, improvements will likely not prevent the continuation of O. viverrini sl transmission, as the feline and canine reservoir hosts will continue to pass on the eggs ().

Opisthorchis viverrini-induced cholangiocarcinoma (CCA) pathway

The World Health Organization has classified O. viverrini sl as a group one carcinogen for its role in inducing CCA.Citation19,Citation20 Initially, liver fluke infections produce acute inflammation of the large hepatic bile ducts and portal connective tissue.Citation21 However, chronic infections and inflammation have been shown to be risk factors for the development of multiple stages of carcinogenesis.Citation22 Despite the ease of treatment with and mass distribution of the anti-helminthic drug, praziquantel, multiple reinfection is common and infections tend to be chronic.Citation15

In chronic infections, hyperplasia, adenomatous formations, and granulomatous inflammation can be seen in the bile duct epithelium.Citation21 These are caused by mechanical injury and fluke metabolic products. Oral and ventral suckers of the fluke cause mechanical damage during the processes of feeding and migration, leading to ulceration of the periductal tissue. This allows fluke eggs to enter the tissue, which in turn cause granulomatous inflammation of the tissue around them.Citation15 Fluke metabolic products may be toxic or immunogenic and can interact with the bile duct epithelium to induce hyperplasia.Citation23 Infiltration of inflammatory cells has been linked to the presence of O. viverrini sl antigens, including in areas where the liver flukes themselves are not found (eg, bile ducts too small in diameter for the flukes to enter).Citation15,Citation21 It has been suggested that this inflammation could be mediated by parasite-specific inflammatory cytokine interleukin (IL)-6 and later it was demonstrated that elevated IL-6 to O. viverrini sl excretory/secretory substance levels were linked to an increased risk of 63% for developing advanced PDF (a symptom of chronic O. viverrini sl infection and indicator for high risk of CCA development) and that individuals in the third quartile of IL-6 production had a 127% higher risk of developing advanced PDF than individuals in the first quartile of IL-6 production.Citation17 It is now well established that chronic inflammation caused by long-term or repeated O. viverrini sl infections plays a large part in the development of many of the factors and events that lead to CCA, most notably the increased production of nitric oxide (NO).Citation24Citation27

NO, as well as other oxygen radicals, such as superoxide (O2), are produced in chronically inflamed tissues (using inducible NO synthase, or iNOS, in the case of NO) as an immune response aimed at killing the parasite.Citation25 Parasite-specific T cells and cytokines activate cells such as macrophages, mast cells, eosinophils, and epithelial cells to synthesize NO, which is both cytotoxic (cell damaging) and genotoxic (damaging to DNA).Citation28 This is largely as a result of the formation of reactive oxygen species and reactive nitrogen species (ROS/RNS). NO can react with superoxide to produce peroxynitrite (ONOO), a highly reactive molecule that can cause oxidative and nitrative DNA damage through the formation of DNA adducts such as 8-oxo-7,8-dihydro-2′-deoxyguanosine (8oxodG) and 8-nitroguanine.Citation26 This resultant DNA damage has been linked to an increase in cell proliferation caused by proliferating cell nuclear antigen (PCNA) accumulation in the bile duct epithelium (especially with repeat infections).Citation29 As well as this, NO has been shown to further increase the possibility for carcinogenesis through DNA repair inhibition and inhibiting apoptosis.Citation30Citation32 Excess production of NO, as a result of long-term O. viverrini sl infection and inflammation, may also increase the potential for the endogenous synthesis of N-nitrosamines, such as the carcinogenic N-dimethylnitrosamine (NDMA). This reaction has been shown to occur within the inflamed bile duct.Citation28,Citation33,Citation34 NDMA levels have been associated with a lymphoproliferative response to O. viverrini sl antigens and can be detected in the urine of infected individuals.Citation35

Another effect of inflammation-linked ROS/RNS is lipid peroxidation. Products of the oxidization of lipids (such as trans-4-hydroxy-2-nonenal) can react with DNA bases to form the etheno-DNA adducts 1,N6-etheno-2′-deoxyadenosine (εdA) and 3,N4-etheno-2′-deoxycytidine (εdC).Citation36 These lesions can initiate carcinogenesis through specific base pair substitutions and have been shown to accumulate in the white blood cells of O. viverrini sl-infected individuals, alongside 8-oxodG.Citation36 The presence of the DNA adducts, 8oxodG and 8-nitroguanine, in the bile duct epithelium and the presence of NDMA in the urine of O. viverrini sl-infected individuals cease with praziquantel treatment, strongly pushing the link between these effects and O. viverrini sl infection.Citation35,Citation37 The amount of the DNA adducts, εdA and εdC, is also significantly lowered by antiparasitic drug treatment and can also be measured in the urine.Citation36 Without praziquantel treatment, 8-nitroguanine and 8-oxodG were shown to remain present in the epithelium of hamsters 180 days after they were infected.Citation29 However, reinfection was shown to increase the rate of inflammatory cell infiltration, iNOS expression in the epithelium, production of NO, and formation of 8-nitroguanine and 8oxodG with each reinfection – ultimately increasing DNA damage and risk of cancer development.Citation29 This raises the question as to whether or not it is best to treat individuals who are at a high risk of reinfection with praziquantel, as it could do more harm than good. There are many social and moral complications to this question, but more research into the effects of the drug and of reinfection could help come closer to finding the answer.

The diminishing immune response to a chronic O. viverrini sl infection may partly help to explain why multiple reinfection can be more damaging than one chronic infection, but also suggests that immunosuppression occurs.Citation38 Over time, a gradual decrease in inflammation can be seen with an associated increase in PDF – one of the key stages and identifiers of risk for CCA development.Citation29 Throughout the infection inflammation process, progressive destruction and remodeling of the bile duct epithelium occurs, alongside an increase in synthesis of type I and type III collagen.Citation17,Citation39 The linkage of PDF to increased risk for CCA development means that in Northeast Thailand, the presence of PDF is used to identify the “at-risk” group for enhanced ultrasound scanning scheduling.Citation40

Interactions between risk factors

Lifestyle-related health risks and genetic polymorphisms may interact with the effects of O. viverrini sl infection to enhance the potential carcinogenic effects. In animal models of O. viverrini sl infections, nitrosamines have been shown to be an important element of cholangiocarcinogenesis.Citation41 The diet in Northeast Thailand, popularly containing fermented, dried, or salted fish and pork, is high in preformed nitrosamines and therefore may be a key cause of high CCA prevalence beyond risk of containing metacercariae.Citation42 There are also frequently high levels of these in well water in Northeast Thailand.Citation43 Alcohol and smoking, particularly in conjunction with one another, may enhance the carcinogenic effect of O. viverrini sl infection. Smoking further introduces nitrosamines into the body, alongside its many other well-known carcinogenic contents.Citation44 Alcohol affects nitrosamine metabolism, distribution, and carcinogenic effect, thereby creating a greater risk of carcinogenesis for those with high nitrosamine intakes.Citation45 Genetic polymorphisms such as the null variant of glutathione-S-transferase enzyme (GSTM1) may also increase cancer risk in combination with O. viverrini sl infection. The ineffective form of this carcinogen detoxifying enzyme is thought to lead to an increase in endogenous nitrosamine production in O. viverrini sl-infected individuals and an increased carcinogenic effect.Citation43 There are many other biliary tract-affecting disorders that are linked to CCA incidence, such as primary sclerosing cholangitis, congenital fibropolycystic liver disease, bile duct adenomas, biliary papillomatosis, hepatolithiasis, and cirrhosis, and there are even weak links to hepatitis B and C.Citation46 However, very little research published into the combined effects that these might have with O. viverrini sl infection exists. Another emerging risk factor for CCA is asbestos exposure.Citation47 It would be interesting to explore the extent of impact this may have had in Southeast Asia, particularly in conjunction with O. viverrini sl infection. Further research may give greater insight into the effects that combinations of risk factors can have on the risk of an O. viverrini sl infection and perhaps help to shape education and policy on the matter in Southeast Asia.

Renal comorbidity

Renal pathologies have been found to develop secondary to hepatobiliary abnormalities. In a study with hamsters infected with O. viverrini sl, mesangioproliferative glomerulopathy developed after 8 weeks, followed by tubular atrophy and fibrosis, as well as amyloid deposition, all coinciding with PDF and CCA.Citation48 One study found immunoglobulins to O. viverrini sl antigens in the urine, suggestive of glomerulonephritis, and concluded IgG against O. viverrini sl may have potential as a biomarker due to the positive correlation with the disease progression.Citation49 This is thought to be caused by the deposition of immune complexes resulting in the chemoat-traction of leukocytes and inflammation, thus increasing glomerular pore size. The greater the pore size, the more IgG reaches the urine, to such a level that it overloads the reabsorption capacity of the proximal tubule.Citation50,Citation51 This aspect of opisthorchiasis deserves more research to allow the disease to be correctly diagnosed and treated as a syndrome.

Diagnosis

Formalin–ethyl acetate sedimentation concentration technique (FECT) is currently seen as the gold standard for determining O. viverrini sl infection and uses a microscope to count any eggs present in the feces and quantify the intensity of infection in eggs per gram (epg).Citation52,Citation53

FECT is a simple, noninvasive procedure, but requires an experienced microscopist, due to the frequently low egg output of individuals, and also several samples and repeats to reduce false-negatives.Citation52 This method also relies on the parasites having reached the level of maturity required to release eggs into the gastrointestinal tract, which leads to a low specificity as eggs may not be present despite an O. viverrini sl infection. Furthermore, O. viverrini sl eggs can be easily confused with those of other parasites, such as minute intestinal flukes, leading to false-positives.Citation54 Thus, FECT is often used alongside monoclonal antibody-based (mAb) enzyme-linked immunosorbent assay (ELISA) or indirect antibody ELISA.

mAb ELISA detects O. viverrini sl antigens in the feces, or coproantigens, and is more sensitive than FECT. It does not cross-react with flukes, unlike indirect antibody ELISA, but it only detects current infections, while indirect antibody ELISA can detect past infections, as antibodies persist in body fluids following treatment with praziquantel.Citation55 Those with past infections are still at risk of CCA, and so indirect antibody ELISA is helpful for identifying this cohort.

Indirect antibody ELISA is used when only a blood or urine sample is available. While antibody levels are higher in serum, urine is a noninvasive alternative that does not require rapid processing or a trained phlebotomist.Citation56 Both the ELISA tests are more sensitive to scanty O. viverrini sl infections than is FECT. The prevalence of O. viverrini sl infections means it is likely that some individuals have an infection with worms that have yet to reach maturity and so do not release eggs, demonstrating the need for ELISA to be used to confirm the FECT result and prevent false-negatives.Citation57

The next step is to determine the extent of the disease. The presenting symptoms of CCA cannot provide a differential diagnosis, and so imaging and endoscopic techniques are often used to diagnose PDF and CCA.Citation58 Ultrasound is the primary imaging tool in Southeast Asia due to its low cost and portability. It is sensitive to bile duct dilation and can detect PDF, but not malignancy. Therefore, MRI and CT scans are performed at the hospital if abnormalities are found.Citation59 Both CT and MRI can determine malignancy, but MRI provides superior soft-tissue resolution, can determine periductal infiltration and the extent of localization of a tumor, and can identify small lesions to a higher degree than CT.Citation60,Citation61 However, CT scans cost less and so are widely used in Southeast Asia as an alternative.Citation62 An endoscopic retrograde cholangiopancreatography (ERCP) is used to image the biliary tree while also obtaining biliary brushings and bile samples for histopathology and cytology.Citation63,Citation64 However, the fibrous nature of the tumor can lead to low yields in sample collection, and a range of other sampling and interpretive errors decrease the specificity of this technique.Citation65,Citation66 There is also a therapeutic value as plastic or self-expanding metal stents can be deployed to allow biliary drainage.Citation67 Magnetic resonance cholangiopancreatography (MRCP) is a magnetic resonance imaging scan optimized for the biliary and pancreatic ducts and is increasingly preferred as the diagnostic test of choice due to its noninvasive nature as opposed to ERCP.Citation68 Using the high water content of bile as a contrast medium, it is an excellent technique for assessing biliary obstruction and localization of lesions, but ERCP is still often needed for biopsies and deploying stents.Citation69

All current available biomarkers lack specificity and sensitivity, and so the present research focuses on reliable biomarkers to allow early monitoring of opisthorchiasis.Citation70,Citation71

Biomarkers

Imaging PDF is extremely subjective; hence, biomarkers are needed to determine individuals at risk of developing CCA to monitor the disease.Citation72 CCA has multiple pathways, and so, ideally, multiple biomarkers are needed to cover all pathways, requiring different avenues of research.Citation73

One such approach used magnetic resonance spectroscopy to analyze the chemical composition of bile in individuals with CCA against controls and assess if any differing molecules could be used as biomarkers. Using multivariate pattern-recognition analysis, CCA samples were successfully discriminated for non-CCA samples with a sensitivity of 80% and specificity of 95%, with phosphatidylcholine, H-18 bile acids, and taurine-conjugated bile acid being the most useful metabolites for differentiating the samples.Citation69 Glycine-conjugated bile acids were found to be significantly raised in CCA patients’ bile, leading to the conclusion that primary bile acids, as well as glycine-conjugated bile acids, may have potential for use as biomarkers.Citation69

Products caused by oxidative DNA damage can often be used as biomarkers. Hamsters infected with O. viverrini sl have been shown to express iNOS in the epithelial bile duct cells and inflammatory cells, resulting in an excess of ROS/RNS, and the formation of DNA adducts, such as 8-nitroguanine and 8-oxodG.Citation74 The levels of the two DNA adducts were found to increase with increasing numbers of reinfections.Citation29 8-oxodG was found in leukocytes and significantly correlated with the levels in the urine and with the progression of the disease.Citation75

One study found that urine 8-oxodG levels were significantly different between control individuals (healthy and advanced PDF negative – APF−) and those with advance hepatobiliary disease (CCA and advanced PDF positive – APF+). There was no significant difference between those with CCA and APF.

The area under the curve (AUC) of the receiver–operating characteristic curve to diagnose APF was 0.74 and 0.88 for CCA.Citation76 Thus, 8-oxodG has been classed as robust, accurate, reproducible, and stable; however, as levels are raised in several other cancers, the ability of 8-oxodG to act as a biomarker is diminished.Citation77,Citation78

Immunoglobulins against O. viverrini sl antigens are significantly upregulated throughout the carcinogenesis process and the levels correlate with disease progression.Citation29 The renal abnormalities that occur alongside the hepatobiliary pathologies mean the more advanced the disease, the higher the damage to the glomerulus, allowing more IgG to filter into the urine.Citation47 One study found that >60% of individuals who were APF+, and all of the CCA individuals, tested positive for IgG against O. viverrini sl antigen in the urine, yet nearly all individuals had it in their blood. This implies that only individuals with advanced hepatobiliary pathologies had developed renal complications significant enough for the IgG to be present in the urine. The levels of urine IgG against O. viverrini sl were significantly higher in individuals with hepatobiliary abnormalities as opposed to controls, were able to differentiate between CCA and other stages of opisthorchiasis, and could discriminate between light and heavy O. viverrini sl infections.Citation48

DNA mutations

CpG islands are a potential source of biomarkers and are often methylated in cancers which result in transcriptional silencing.Citation79,Citation80 One study aimed at looking for hypermethylation at certain loci to find prognostic or diagnostic biomarkers.Citation81 In order to analyze the data, a methylation index (MI) was created which was the ratio of the number of methylated CpG islands and the total number of CpG islands looked at.Citation82 The result was that the MI for CCA (0.12) was significantly higher than that for normal tissues (0.02). Opioid binding protein/cell adhesion molecule like gene (OPCML) was the most commonly methylated (72.5%).Citation80 It was not found methylated in normal tissues and was associated with less differentiated CCA, leading to a worse prognosis and increased chance of metastasis.Citation83,Citation84

OPCML is a tumor-suppressor gene and is methylated in several other cancers, such as ovarian cancer, and so is of little use when used alone.Citation85 PTEN, HIC1, and SFRP1 were also all often found to be highly methylated and are thought to play a role in the increase of proliferation and survival advantage as well as having an antiapoptotic effect. Patients who had methylation at the locus of DcR1 were found to have a longer survival than those without, suggesting that DcR1 could be used to indicate the prognosis of CCA patients.Citation80

MicroRNA

Many cancers cause an up/downregulation of certain miRNAs which can be detected in bodily fluids.Citation86 In CCA, the levels of several miRNAs have been found to change, such as miR-141 which increases, and miR-370 which decreases, and miR-21 which was found to correlate with the disease progression in hamsters.Citation71,Citation87,Citation88 One study found that serum miR-192 levels in CCA patients were significantly higher than in healthy subjects, with an AUC of 0.803, but were not significantly increased as the opisthorchiasis progressed.

Despite this, the increase in miR-192 levels throughout the carcinogenesis pathway implies that the increase is caused by parasite-driven inflammation. High levels also carried a significant correlation with lymph node metastasis and decreased survival rates, meaning it can be used as a prognostic marker.Citation89

The use of miR-192 as a biomarker when found in the urine has also been researched, alongside miR-21. In the urine, the miR-192 levels were significantly different between healthy and O. viverrini sl infected, healthy and PDF, and healthy and CCA. Not only this, but the level of miRNA-192 between healthy and other inflammatory diseases was not significant and so can be described as disease specific. miR-21 was found to be significantly higher for PDF, CCA, and other inflammatory diseases as opposed to healthy subjects, making it a useful potential biomarker, although it is not unique for CCA. When the two miRNAs were combined, the results for differentiating between individuals improved and removed the problem of miR-21 not being disease specific.Citation90

Current treatment

Praziquantel is a cheap and effective anti-helminth drug to treat O. viverrini sl infections and was used for mass drug administration in Thailand in the early 1980s to prevent CCA. This effectively reduced the prevalence from 80% to 15%–20% by 1997.Citation91 Although praziquantel will stop parasitic infection, any inflammation and fibrosis in the bile duct that remain will be a risk factor for CCA development. A further problem is that many individuals will become reinfected with O. viverrini sl which may increase the risk for CCA, due to the acute inflammatory phase of reinfection, as opposed to chronic inflammation.Citation92 Therefore, repeat drug administration may increase the risk of cholangiocarcinogenesis if people continue to eat raw fish and get reinfected following praziquantel treatment.

Effective CCA treatment is limited, showing a resistance to chemotherapy, with a very low response rate.Citation93 One study has potentially found a future use for chemotherapy: to prevent TRAIL (Tumor necrosis factor Related Apoptosis Inducing Ligand) resistance. When used in conjunction with recombinant TRAIL, or TRAIL receptor agonistic monoclonal antibodies, it is potentially a selective CCA treatment, as tumor cells are much more sensitive than normal cells to TRAIL-induced apoptosis.Citation80

Nonetheless, in Southeast Asia, the only two current effective treatments are surgical resection and liver transplantation. By the time CCA presents, the prognosis is usually poor, as the tumor is too advanced for resection. While hilar tumors can be aggressively managed with portal embolization alongside liver and portal vein resections, extrahepatic tumor growth is a contraindication for surgery. Reports show that, of those who had a “successful,” that is, R0 resection, the 5-year survival rate was still only 25%–30%, dropping to 0%–12% for patients with positive margins.Citation94,Citation95 A study group from Northeast Thailand managed to gain a promising R0 resection rate of 64% from 83 patients. The 5-year survival for the entire group was 21% while that of the R0 group was 30%.Citation96 Despite a poor general prognosis, when neoadjuvant chemotherapy is used, a 65% cure rate can be achieved with perihilar CCA cases.Citation97

When resection is not an option for intrahepatic CCA, those without any extrahepatic growth may be eligible for liver transplant.Citation93 In the past, liver transplantation was seen as ineffective in treating CCA with a 5-year survival rate of 0%–20% in published series from Kings College London and Hannover.Citation98,Citation99 However, recent studies have given renewed interest in liver transplantation, with a US center achieving a 5-year survival rate of >70% using neoadjuvant chemotherapy with a carefully selected group.Citation100 Another group in Scandinavia achieved a 50% 5-year survival rate, again with highly stringent patient selection.Citation101 Typically, these cases involve very small tumors, which are deemed nonresectable, and occur on the perihilar region of the liver. Only a few percent of those considered are deemed eligible. These studies indicate that instead of seeing liver transplantation as a poor alternative, the guidelines for which patients are eligible should be more stringent.

Immunotherapy is a promising new treatment to be used adjuvantly to surgery and/or chemotherapy. The presence of leukocytes in infected sites allows for exploitation of the immune system to fight the tumor.Citation102 Personal peptide vaccines, which immunize the patient against a host of antigens, and dendritic vaccines, which immunize against one antigen with no need for processing and a reduced autoimmunity are both significantly more effective used adjuvantly with chemotherapy compared to chemotherapy alone.Citation103 As well as with chemotherapy, dendritic vaccines resulted in an average survival time of 17.4 months when administered alongside surgery compared to 7.7 months for surgery alone.Citation104 A meta-analysis found that a higher expression of immune active factors resulted in a significantly better prognosis (P<0.00001) and that altering the tumor microenvironment to increase the T-cell infiltration significantly increased the 6-month progression-free survival rate (P<0.05).Citation101 Cytotoxic T-lymphocyte antigen 4 and the interaction between programmed cell death 1 (PD1) and its ligand (PDL1) are pathways the tumor uses to evade the immune system. Passive immunotherapy uses monoclonal antibodies to block these interactions so the immune system can fight the tumor. However, while this has been done in other malignancies such as melanoma, there is no published data on the efficacy against CCA.Citation105

When the tumor is too advanced for curative treatment, the only other option is palliative care. In Northeast Thailand, over 95% of cases have stage 4 CCA and so 70%–80% of patients receive palliative treatment using stents for biliary drainage.Citation106,Citation107 The high number of stage 4 CCA cases highlights the need for research into earlier diagnosis to find cases earlier on in their progression.

Summary

The high rate of O. viverrini sl infection in Southeast Asia has led to Northeast Thailand having the highest incidence of CCA in the world. Infection with the liver fluke can be easily diagnosed with FECT or ELISA, with praziquantel being used as treatment. However, due to CCA-afflicted individuals remaining asymptomatic until the end stages of the disease, the cure rate without early diagnosis and intervention is dire. Thus, ultrasounds are now routinely used to screen individuals for potentially early stages of CCA or those in the risk group with PDF. MRI and CT scans are used further to evaluate potential malignancy and ERCPs can be used for further confirmation. O. viverrini sl has also been implicated in renal pathology, caused by an immune response with resultant glomerulonephritis. The resulting IgG found in urine has the potential to be used as a syndromic biomarker. Research into biomarkers from various aspects of the carcinogenic pathway is now underway to detect CCA in the early stages and allow for a higher chance of successful intervention.

Conclusion

To best combat CCA in Southeast Asia in the short term, research should focus on early and better diagnosis of CCA and its warning signs. Continued effort to produce a range of biomarkers for various stages of the carcinogenic pathway could lead to a dramatically reduced mortality rate and better prognoses for patients. Longer-term future public education schemes, such as those organized by the Cholangiocarcinoma Screening and Care Program (CASCAP), should continue to be introduced and expanded to teach communities about the dangers of eating certain types of raw, partially cooked, or fermented fish, and perhaps over time, practices will evolve concerning “raw attitudes.”Citation14 Investigation into the under-researched renal effects of opisthorchiasis could also garner some insight into the complicated effect of long-term O. viverrini infection and how it can be tackled as a syndrome.

Acknowledgments

All authors acknowledge the support of the National Institute for Health Research Biomedical Research Centre at Imperial College London for infrastructure support. SDT-R hold grants from the United Kingdom Medical Research Council. The collaboration was supported by a Wellcome Trust ISSF grant to Imperial College London. PS and RHA were supported by grants from the Thailand Research Fund (TRF). The authors would like to thank Dr Shahid Khan and Mary Crossey for their help and advice on the content of this review, and Nadda Kiatsopit for producing .

Disclosure

The authors report no conflicts of interest in this work.

References

  • KeiserJUtzingerJFood-borne trematodiasesClin Microbiol Rev200922346648319597009
  • AndrewsRHSithithawornPPetneyTNOpisthorchis viverrini: an underestimated parasite in world healthTrends Parasitol2008241149750118930439
  • SaijunthaWSithithawornPWongkhamSEvidence of a species complex within the food-borne trematode Opisthorchis viverrini and possible co-evolution with their first intermediate hostsInt J Parasitol200737669570317275001
  • SithithawornPAndrewsRHPetneyTNSaijunthaWLaopromNThe systematics and population genetics of Opisthorchis viverrini sensu lato: implications in parasite epidemiology and bile duct cancerParasitol Int2012611323721821147
  • KiatsopitNSithithawornPSaijunthaWPetneyTNAndrewsRHOpisthorchis viverrini: implications of the systematics of first intermediate hosts, Bithynia snail species in Thailand and Lao PDRInfect Genet Evol20131431331923305887
  • BrockelmanWYUpathamESViyanantVArdsungnoenSChantanawatRField studies on the transmission of the human liver fluke, Opisthorchis viverrini, in northeast Thailand: population changes of the snail intermediate hostInt J Parasitol19861655455523781736
  • NamsanorJSithithawornPKopolratKSeasonal transmission of Opisthorchis viverrini sensu lato and a lecithodendriid trematode species in Bithynia siamensis goniomphalos snails in northeast Thai-landAm J Trop Med Hyg20159318793
  • KiatsopitNSithithawornPSaijunthaWExceptionally high prevalence of infection of Bithynia siamensis goniomphalos with Opisthorchis viverrini cercariae in different wetlands in Thailand and Lao PDRAm J Trop Med Hyg201286346446922403318
  • HaasWGranzerMBrockelmanCROpisthorchis viverrini: finding and recognition of the fish host by the cercariaeExp Parasitol19907144224312226703
  • SithithawornPYongvanitPDuenngaiKKiatsopitNPairojkulCRoles of liver fluke infection as risk factor for cholangiocarcinomaJ Hepatobiliary Pancreat Sci201421530130824408775
  • SithithawornPHaswell-ElkinsMEpidemiology of Opisthorchis viverriniActa Trop200388318719414611873
  • KopolratKSithithawornPKiatsopitNComparison of infectivity, metacercarial burden and host mortality induced by Opisthorchis viverrini sensu lato cercariae from Lao PDR compared with Thailand in cyprinid fish, Barbonymus gonionotusTrans R Soc Trop Med Hyg20161101465426740362
  • DonthaisongCArunsanPSuwannatraiKExperimental infection of Opisthorchis viverrini cercariae to the cyprinid fish, Barbonymus gonionotusActa Trop201413611812224780189
  • Grundy-WarrCAndrewsRHSithithawornPRaw attitudes, wetland cultures, life-cycles: socio-cultural dynamics relating to Opisthorchis viverrini in the Mekong BasinParasitol Int2012611657021712097
  • SripaBKaewkesSSithithawornPLiver fluke induces cholangiocarcinomaPLoS Med200747e20117622191
  • MacphersonCNHuman behaviour and the epidemiology of parasitic zoonosesInt J Parasitol20053511–121319133116102769
  • SripaBMairiangEThinkhamropBAdvanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6Hepatology20095041273128119676135
  • EnesJEWagesAJMaloneJBTesanaSPrevalence of Opisthorchis viverrini infection in the canine and feline hosts in three villages, Khon Kaen Province, northeastern ThailandSoutheast Asian J Trop Med Public Health2010411364220578480
  • YoungNDCampbellBEHallRSUnlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverriniPLoS Negl Trop Dis201046e71920582164
  • World Health OrganisationBiological agents–a review of human carcinogensIARC Monogr Eval Carcinog Risks Hum2014100B341371
  • BhamarapravatiNThammavitWVajrasthiraSLiver changes in hamsters infected with a liver fluke of man, Opisthorchis viverriniAm J Trop Med Hyg1978274787794686245
  • MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
  • PungpakSChalermrutKHarinasutaTOpisthorchis viverrini infection in Thailand: symptoms and signs of infection–a population-based studyTrans R Soc Trop Med Hyg19948855615647992340
  • HolzingerFZ’GraggenKBuchlerMWMechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinomaAnn Oncol199910Suppl 412212610436802
  • OhshimaHBartschHChronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesisMutat Res199430522532647510036
  • InoueSKawanishiSOxidative DNA damage induced by simultaneous generation of nitric oxide and superoxideFEBS Lett1995371186887664890
  • KawanishiSHirakuYOxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammationAntioxid Redox Signal200685–61047105816771694
  • YongvanitPPinlaorSBartschHOxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesisParasitol Int201261113013521704729
  • PinlaorSSripaBSithithawornPYongvanitPHepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverriniExp Parasitol20041081–2323915491546
  • JaiswalMLaRussoNFBurgartLJGoresGJInflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanismCancer Res200060118419010646872
  • JaiswalMLaRussoNFShapiroRABilliarTRGoresGJNitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytesGastroenterology2001120119019911208728
  • TorokNJHiguchiHBronkSGoresGJNitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9Cancer Res20026261648165311912135
  • SrivatanakulPOhshimaHKhlatMOpisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in ThailandInt J Cancer19914868218251650329
  • SatarugSHaswell-ElkinsMRTsudaMThiocyanate-independent nitrosation in humans with carcinogenic parasite infectionCarcinogenesis1996175107510818640916
  • SatarugSHaswell-ElkinsMRSithithawornPRelationships between the synthesis of N-nitrosodimethylamine and immune responses to chronic infection with the carcinogenic parasite, Opisthorchis viverrini, in menCarcinogenesis19981934854919525284
  • DechakhamphuSPinlaorSSitthithawornPNairJBartschHYongvanitPLipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantelCancer Epidemiol Biomarkers Prev201019131031820056652
  • PinlaorSHirakuYYongvanitPiNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantelInt J Cancer200611951067107216570287
  • SripaBKaewkesSRelationship between parasite-specific antibody responses and intensity of Opisthorchis viverrini infection in hamstersParasite Immunol200022313914510672195
  • ChotigeatWRuenwongsaPTypes of collagen in Opisthorchis viverrini infected hamster liverMol Biochem Parasitol19861833773873960058
  • MairiangEElkinsDBMairiangPRelationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonographyJ Gastroenterol Hepatol19927117211311966
  • ThamavitWBhamarapravatiNSahaphongSVajrasthiraSAngsubhakornSEffects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamstersCancer Res1978381246344639214229
  • SrivatanakulPSukaryodhinSOhshimaHOpisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in ThailandInt J Cancer1991488218251650329
  • HonjoSSrivatanakulPSriplungHGenetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast ThailandInt J Cancer200511785486015957169
  • TrickerARN-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluidsEur J Cancer Prev1997632262689306073
  • SwannPFEffect of ethanol on nitrosamine metabolism and distribution Implications for the role of nitrosamines in human cancer and for the influence of alcohol consumption on cancer incidenceIARC Sci Publ198457501512
  • KhanSAToledanoMBTaylor-RobinsonSDEpidemiology, risk factors, and pathogenesis of cholangiocarcinomaHPB200810778218773060
  • BrandiGDi GirolamoSFarioliAAsbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysisCancer Causes Control201324591191823408245
  • BoonpucknavigSBoonpucknavigVTanvanichSDoungchaweeGThamavitWDevelopment of immune-complex glomerulonephritis and amyloidosis in Syrian golden hamsters infected with Opisthorchis viverriniJ Med Assoc Thai199275Suppl 17191402485
  • SaichuaPSithithawornPJariwalaARMicroproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasisPLoS Negl Trop Dis201375e222823717698
  • D’AmicoGBazziCPathophysiology of proteinuriaKidney Int200363380982512631062
  • LevinskyRJRole of circulating immune complexes in renal diseasesJ Clin Pathol19813411121412226459344
  • CDC-DPDxDPDx – Laboratory Identification of Parasitic Diseases of Public Health ConcernDPDx – Laboratory Identification of Parasitic Diseases of Public Health Concern2016DPDx – Laboratory Identification of Parasitic Diseases of Public Health ConcernAccessed March 19, 2016
  • JohansenMVLierTSithithawornPTowards improved diagnosis of neglected zoonotic trematodes using a One Health approachActa Trop2015141Pt B16116923886849
  • UtzingerJBrattigNWLeonardoLZhouXNBergquistRProgress in research, control and elimination of helminth infections in AsiaActa Trop2015141Pt B13514525446170
  • JamornthanyawatNThe diagnosis of human opisthorchiasisSoutheast Asian J Trop Med Public Health200233Suppl 38691
  • SawangsodaPSithithawornJTesanaSDiagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasisParasitol Int201261119620221704727
  • WorasithCKamamiaCYakovlevaAAdvances in the diagnosis of human opisthorchiasis: development of Opisthorchis viverrini antigen detection in urinePLoS Negl Trop Dis2015910e000415726485024
  • NakeebAPittHASohnTACholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumorsAnn Surg19962244463473 discussion 473–4658857851
  • ZabronAEdwardsRJKhanSAThe challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancerDis Model Mech20136228129223520144
  • ChamadolNPairojkulCKhuntikeoNHistological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patientsJ Hepatobiliary Pancreat Sci201421531632224420706
  • WadsworthCALimATaylor-RobinsonSDKhanSAThe risk factors and diagnosis of cholangiocarcinomaHepatol Int20137237739326201772
  • IbrahimRSSMazliMAmrizalMAljunidSCost of magnetic resonance imaging (MRI) and computed tomography (CT) scan in UKMMCBMC Health Serv Res20121211122233877
  • KhanSADavidsonBRGoldinRGuidelines for the diagnosis and treatment of cholangiocarcinoma: consensus documentGut200251Suppl 6VI1912376491
  • BobergKMJebsenPClausenOPFossAAabakkenLSchrumpfEDiagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitisJ Hepatol200645456857416879890
  • WeberAvon WeyhernCFendFEndoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinomaWorld J Gastroenterol20081471097110118286693
  • The Free DictionaryBiliary brushing2016 Available from: http://medical-dictionary.thefreedictionary.com/biliary+brushingAccessed September 7, 2016
  • SoderlundCLinderSCovered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trialGastrointest Endosc200663798699516733114
  • PrasadSRSahaniDSainiSClinical applications of magnetic resonance cholangiopancreatographyJ Clin Gastroenterol200133536236611606850
  • RomagnuoloJBardouMRahmeEJosephLReinholdCBarkunANMagnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary diseaseAnn Intern Med2003139754755714530225
  • SharifAWWilliamsHRLampejoTMetabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopyHPB (Oxford)201012639640220662790
  • AlvaroDSerum and bile biomarkers for cholangiocarcinomaCurr Opin Gastroenterol200925327928419396965
  • YongvanitPPinlaorSLoilomeWRisk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinomaJ Hepatobiliary Pancreat Sci201421530931524408859
  • KelloffGJBooneCWCrowellJARisk biomarkers and current strategies for cancer chemopreventionJ Cell Biochem Suppl199625114
  • PinlaorSYongvanitPHirakuY8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverriniBiochem Biophys Res Commun2003309356757112963027
  • ThananRMurataMPinlaorSUrinary 8-oxo-7,8-dihydro-2′-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesisCancer Epidemiol Biomarkers Prev200817351852418349269
  • SaichuaPYakovlevaAKamamiaCLevels of 8-oxodG predict hepatobiliary pathology in Opisthorchis viverrini endemic settings in ThailandPLoS Negl Trop Dis201597e000394926230769
  • European Standards Committee on Urinary Lesion AEvansMDOlin-skiRLoftSCookeMSToward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a noninvasive biomarker of oxidative stressFASEB J20102441249126019966135
  • GabrielliASvegliatiSMoronciniGAmicoDNew insights into the role of oxidative stress in scleroderma fibrosisOpen Rheumatol J20126879522802906
  • IllingworthRSBirdAPCpG islands–‘a rough guide’FEBS Lett2009583111713172019376112
  • EstellerMEpigenetics provides a new generation of oncogenes and tumour-suppressor genesBr J Cancer200694217918316404435
  • SriraksaRZellerCEl-BahrawyMACpG-island methylation study of liver fluke-related cholangiocarcinomaBr J Cancer201110481313131821448164
  • GutierrezMISirajAKKhaledHKoonNEl-RifaiWBhatiaKCpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancerMod Pathol200417101268127415154012
  • NakajimaTKondoYMiyazakiMOkuiKA histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreadingHum Pathol19881910122812342844646
  • World Health OrganisationPathology and Genetics of Tumours of the Digestive System1 edLyonIARC Press2000
  • TeodoridisJMHallJMarshSCpG island methylation of DNA damage response genes in advanced ovarian cancerCancer Res200565198961896716204069
  • KosakaNIguchiHOchiyaTCirculating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosisCancer Sci2010101102087209220624164
  • MengFHensonRLangMInvolvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell linesGastroenterology200613072113212916762633
  • MengFWehbe-JanekHHensonRSmithHPatelTEpigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytesOncogene200827337838617621267
  • SilakitRLoilomeWYongvanitPCirculating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicatorJ Hepatobiliary Pancreat Sci2014211286487225131257
  • SilakitRLoilomeWYongvanitPUrinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk groupParasitol Int201566447948526456596
  • JongsuksuntigulPImsomboonTOpisthorchiasis control in ThailandActa Trop200388322923214611877
  • Kamsa-ArdSLuviraVPugkhemAAssociation between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control studyBMC Cancer20151577626496745
  • ScheithauerWReview of gemcitabine in biliary tract carcinomaSemin Oncol2002296 Suppl 204045
  • FrimanSCholangiocarcinoma – current treatment optionsScand J Surg20111001303421491796
  • JangJYKimSWParkDJActual long-term outcome of extrahepatic bile duct cancer after surgical resectionAnn Surg20052411778415621994
  • LangHSotiropoulosGCSgourakisGOperations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patientsJ Am Coll Surg2009208221822819228533
  • LuoXYuanLWangYGeRSunYWeiGSurvival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort studyJ Gastrointest Surg201418356257224395070
  • RingeBWittekindCBechsteinWOBunzendahlHPichlmayrRThe role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrenceAnn Surg1989209188982535924
  • O’Grady JPRJRollesKWilliamsRLiver transplantation for malignant diseaseAnn Surg1988207473337564
  • RosenCBHeimbachJKGoresGJLiver transplantation for cholangiocarcinomaTranspl Int201023769269720497401
  • FrimanSFossAIsoniemiHLiver transplantation for cholangiocarcinoma – selection is essential for acceptable resultsScand J Gastroenterol201146337037521073376
  • WangYDingMZhnagQActivation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysisJ Cancer201781748428123600
  • MarksEIYeeNSImmunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategiesWorld J Gastrointest Oncol201571133834626600933
  • TakahashiRYoshitomiMYutaniSCurrent status of immunotherapy for the treatment of biliary tract cancerHum Vaccin Immunother2013951069107223376808
  • GubinMMZhangXSchusterHCaronECheckpoints blockade cancer immunotherapy targets tumour-specific mutant antigensNature2014515752857758125428507
  • WiangnonSKamsa-ardSSuwanrungruangKTrends in incidence of hepatocellular carcinoma, 1990–2009, Khon Kaen, ThailandAsian Pac J Cancer Prev20121331065106822631639
  • MartinRCVitaleGCReedDNLarsonGMEdwardsMJMcMastersKMCost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinomaSurg Endosc200216466767011972211